Overview

Use of Vasopressin Following the Fontan Operation

Status:
Suspended
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Advocate Health Care
Treatments:
Arginine Vasopressin
Polystyrene sulfonic acid
Vasopressins